Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice
Beatriz Carmona‐Hidalgo, Isabel González‐Mariscal, Adela García‐Martín, et al.
Phytomedicine (2020) Vol. 81, pp. 153426-153426
Closed Access | Times Cited: 25

Showing 25 citing articles:

Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
Kenneth B. Walsh, Amanda E. McKinney, Andrea E. Holmes
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 99
The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer’s Disease-like Mouse Model
Juyong Kim, Pilju Choi, Young‐Tae Park, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6827-6827
Open Access | Times Cited: 29
Cannabinoids and Chronic Liver Diseases
Ralph‐Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9423-9423
Open Access | Times Cited: 20
Could Alcohol Abuse and Dependence on Junk Foods Inducing Obesity and/or Illicit Drug Use Represent Danger to Liver in Young People with Altered Psychological/Relational Spheres or Emotional Problems?
Giovanni Tarantino, Mauro Cataldi, Vincenzo Citro
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10406-10406
Open Access | Times Cited: 20
Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPARγ in carbon tetrachloride-treated mice
Lin Zhang, Haibo Zhang, Gu Jin-Hua, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109433-109433
Closed Access | Times Cited: 20
Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research
Diego Caprioglio, Hawraz Ibrahim M. Amin, Orazio Taglialatela‐Scafati, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1084-1084
Open Access | Times Cited: 19
The effect of cannabis-derived terpenes on alveolar macrophage function
Patrick M Greiss, Jacquelyn D. Rich, Geoffrey A. McKay, et al.
Frontiers in Toxicology (2025) Vol. 6
Open Access
E se tea aqueous-ethanol extract ameliorates D-galactose induced oxidative stress and inflammation via the Nrf2 signal pathway
Guiguang Cheng, Meng Zhang, Jinke Zhang, et al.
Food Research International (2025), pp. 116323-116323
Closed Access
Effects of Cannabidiol Oil on Anesthetic Requirements in Cats: MAC Determination and Serum Profiling via Nanoscale Liquid Chromatography–Tandem Mass Spectrometry
Panisara Suriyawongpongsa, Sirirat Niyom, Kannika Wanapinit, et al.
Animals (2025) Vol. 15, Iss. 10, pp. 1393-1393
Open Access
Involvement of the ACE2/Ang-(1–7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19
Taylor Morganstein, Ziyad S. Haidar, Joshua Trivlidis, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12955-12955
Open Access | Times Cited: 22
Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial
Ralph‐Sydney Mboumba Bouassa, Eve Comeau, Yulia Alexandrova, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1811-1811
Open Access | Times Cited: 8
Cannabidiol markedly alleviates skin and liver fibrosis
Carmen del Río, Francisco Ruíz-Pino, María E. Prados, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028)
Ralph‐Sydney Mboumba Bouassa, Judy Needham, Dana Nohynek, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3168-3168
Open Access | Times Cited: 12
Regulation of Expression of Cannabinoid CB2 and Serotonin 5HT1A Receptor Complexes by Cannabinoids in Animal Models of Hypoxia and in Oxygen/Glucose-Deprived Neurons
Jaume Lillo, Iu Raïch, Laura Silva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9695-9695
Open Access | Times Cited: 11
Detrimental Effect of Cannabidiol on the Early Onset of Diabetic Nephropathy in Male Mice
Beatriz Carmona‐Hidalgo, Adela García‐Martin, Eduardo Muñóz, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 863-863
Open Access | Times Cited: 10
Therapeutic potential of agents targeting cannabinoid type 2 receptors in organ fibrosis
Lujain Bader Eddin, Mohamed Fizur Nagoor Meeran, Sandeep B. Subramanya, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 1
Protective Effects of Phytic Acid on CCl4-Induced Liver Fibrosis in Mice
Zhen Xu, Chen Zhao, Tongtong Lan, et al.
Journal of Food Biochemistry (2023) Vol. 2023, pp. 1-11
Open Access | Times Cited: 3
New insights into fibrotic signaling in hepatocellular carcinoma
Shan Liang, Fengling Wang, Weiju Xue, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Environmental carbon tetrachloride exposure disrupts the liver structure and metabolic detoxification function in mice via p38MAPK/NF-κB/NLRP3 pathway
Yuanyuan Wei, Danyang Ma, Yimeng Fan, et al.
Food and Agricultural Immunology (2022) Vol. 33, Iss. 1, pp. 235-251
Open Access | Times Cited: 5
Feasibility of a Randomized, Interventional Pilot Clinical Study of Oral Cannabinoids in People with HIV on Antiretroviral Therapy: CTNPT 028
Ralph‐Sydney Mboumba Bouassa, Judy Needham, Dana Nohynek, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 745-745
Open Access
Medicinal cannabis tea contains variable doses of cannabinoids and no terpenes
Marie Bach Sønderskov, Jørgen B. Hasselstrøm, Rime El-Houri, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 3, pp. 334-344
Open Access
Associations of Cannabis Use, Metabolic Dysfunction-Associated Steatotic Liver Disease, and Liver Fibrosis in U.S. Adults
Yu H. Wu, Fei Fang, Xingliang Fan, et al.
Cannabis and Cannabinoid Research (2024)
Closed Access
Nonneurological aspects of the endocannabinoid system: Nonalcoholic fatty liver disease
Reem Ghazali, Vinood B. Patel
Elsevier eBooks (2023), pp. 507-518
Closed Access
Physiopathology and use of cannabinoids for fibrotic diseases
Carmen del Río, Eduardo Muñóz
Elsevier eBooks (2023), pp. 149-158
Closed Access
Synthesis and biological evaluation of hydroxamate isosteres of acidic cannabinoids
Hawraz Ibrahim M. Amin, Francisco Ruíz-Pino, Juan A. Collado, et al.
Frontiers in Natural Products (2023) Vol. 2
Open Access
Page 1

Scroll to top